For Investors
Our Approach
Opportunity
Efficacy
Evidence
SUPLEXA
Manufacturing
Strategic Focus
Strong IP
For Scientists / Clinicians
Pipeline
Publications
ENLIST Cells
SUPLEXA
Key Findings
Future Potential
Collaboration
For Patients
Newsroom
In the News
Releases and Updates
Media Resources
Media Contact
Publications
About
Our Story
Senior Leadership
Conferences
Shareholder
Contact
For Investors
Our Approach
Opportunity
Efficacy
Evidence
SUPLEXA
Manufacturing
Strategic Focus
Strong IP
For Scientists / Clinicians
Pipeline
Publications
ENLIST Cells
SUPLEXA
Key Findings
Future Potential
Collaboration
For Patients
Newsroom
In the News
Releases and Updates
Media Resources
Media Contact
Publications
About
Our Story
Senior Leadership
Conferences
Shareholder
Contact
For Investors
Our Approach
Opportunity
Efficacy
Evidence
SUPLEXA
Manufacturing
Strategic Focus
Strong IP
For Scientists / Clinicians
Pipeline
Publications
ENLIST Cells
SUPLEXA
Key Findings
Future Potential
Collaboration
For Patients
Newsroom
In the News
Releases and Updates
Media Resources
Media Contact
Publications
About
Our Story
Senior Leadership
Conferences
Shareholder
Contact
View all conferences
May 5, 2020
Cancer Progress Meeting
‘Paradigm-shifting Platforms: Taking Immuno-Oncology to the Next Level’
